E-LIB Suche - Ergebnisse für: Ahmadi, Tahamtan

1

Daratumumab for patients with myeloma with early or late re..:

Spencer, Andrew ; Moreau, Philippe ; Mateos, Maria-Victoria...
Blood Advances. 8 (2024) 2 - p. 388-398 , 2024

Link: https://doi.org/10.1182/..

2

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology. 11 (2024) 8 - p. e593-e605 , 2024

Link: https://doi.org/10.1016/..

3

Preclinical anti-tumour activity of HexaBody-CD38, a next-g..:

Hiemstra, Ida H. ; Santegoets, Kim C.M. ; Janmaat, Maarten L....
eBioMedicine. 93 (2023) - p. 104663 , 2023

Link: https://doi.org/10.1016/..

4

Semimechanistic Physiologically‐Based Pharmacokinetic/Pharm..:

Li, Tommy ; Hiemstra, Ida H. ; Chiu, Christopher...
Clinical Pharmacology & Therapeutics. 112 (2022) 5 - p. 1108-1119 , 2022

Link: https://doi.org/10.1002/..

5

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent..:

Muik, Alexander ; Altintas, Isil ; Gieseke, Friederike...
OncoImmunology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

6

DuoBody-CD40x4-1BB induces dendritic-cell maturation and en..:

Muik, Alexander ; Adams 3rd, Homer C ; Gieseke, Friederike...
Journal for ImmunoTherapy of Cancer. 10 (2022) 6 - p. e004322 , 2022

Link: https://doi.org/10.1136/..

7

Poster: MM-155: Phase 3 MAIA Study: Overall Survival (OS) R..:

Orlowski, Robert ; Facon, Thierry ; Kumar, Shaji...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S252 , 2021

Link: https://doi.org/10.1016/..

8

Dose escalation of subcutaneous epcoritamab in patients wit..:

Hutchings, Martin ; Mous, Rogier ; Clausen, Michael Roost...
The Lancet. 398 (2021) 10306 - p. 1157-1169 , 2021

Link: https://doi.org/10.1016/..

9

MM-155: Phase 3 MAIA Study: Overall Survival (OS) Results w..:

Orlowski, Robert ; Facon, Thierry ; Kumar, Shaji...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S424-S425 , 2021

Link: https://doi.org/10.1016/..

10

Enduring efficacy and tolerability of daratumumab in combin..:

Plesner, Torben ; Arkenau, Hendrik‐Tobias ; Gay, Francesca...
British Journal of Haematology. 186 (2019) 3 - p. , 2019

Link: https://doi.org/10.1111/..

11

Effects of daratumumab on natural killer cells and impact o..:

Casneuf, Tineke ; Xu, Xu Steven ; Adams III, Homer C....
Blood Advances. 1 (2017) 23 - p. 2105-2114 , 2017

Link: https://doi.org/10.1182/..

12

Influence of Disease and Patient Characteristics on Daratum..:

Yan, Xiaoyu ; Clemens, Pamela L. ; Puchalski, Thomas...
Clinical Pharmacokinetics. 57 (2017) 4 - p. 529-538 , 2017

Link: https://doi.org/10.1007/..

13

Phase 1b Study of Daratumumab plus Pomalidomide and Dexamet..:

Chari, Ajai ; Suvannasankha, Attaya ; Fay, Joseph...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e14-e15 , 2017

Link: https://doi.org/10.1016/..

14

Analysis of Real-World Data on Overall Survival in Multiple..:

Usmani, Saad ; Ahmadi, Tahamtan ; Ng, Yvette...
The Oncologist. 21 (2016) 11 - p. 1355-1361 , 2016

Link: https://doi.org/10.1634/..

15

Pharmacokinetics of Daratumumab Following Intravenous Infus..:

Clemens, Pamela L. ; Yan, Xiaoyu ; Lokhorst, Henk M....
Clinical Pharmacokinetics. 56 (2016) 8 - p. 915-924 , 2016

Link: https://doi.org/10.1007/..